E2006 2.5 mg
Sponsors
Eisai Inc.
Conditions
Healthy VolunteersInsomnia
Phase 1
A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006
CompletedNCT01463098
Start: 2011-10-05End: 2012-08-11Updated: 2020-01-18
A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects
CompletedNCT02039089
Start: 2014-01-31End: 2014-05-31Updated: 2015-11-03